Background: Early surgical treatment is important for successful outcome in
selected cases of active, either native (NVE) or prosthetic valve endocard
itis (PVE). The aim of this study was to evaluate the early results of the
surgical treatment of active NVE and PVE.
Methods: During a 3-yr period (January 1 1996-December 31 1998), 57 out of
60 patients (pts) with active, either NVE (46 pts) or PVE (11 pts) underwen
t surgical treatment. There were 11 women (23.9%), average age of the group
being 43.3 +/- 9.1 yr (18-73). They were operated on 12-35 days, mean 17.7
+/- 7.5 days (for NVE) and 5-33 days, mean 13.2 +/- 10.1 days (for PVE) af
ter the diagnosis of endocarditis was first suspected. All pts had at least
one absolute indication for early surgical treatment, the most frequent be
ing (in NVE) worsening heart failure (19 cases) and inability to control th
e infection (10 cases). while in PVE it was valve dehiscence (8 cases). In
8 cases of NVE and 2 cases of PVE fresh, antibiotic sterilized aortic homog
raft was used to replace the aortic valve.
Results: Operative mortality was 1.8% (1/57) and hospital mortality 5.2% (3
/57). Three pts with PVE died before they were operated on, giving an overa
ll mortality of 10% (6/60). Post-operative morbidity included valve dehisce
nce in two pts (probable late onset recurrent endocarditis - 3.5%), three e
pisodes of acute renal failure (5.3%), four cases of respiratory insufficie
ncy (7.0%) and one chronic pleural effusion (1.8%). All pts that were disch
arged from the hospital (54/60), are still alive and well 1-35 months posto
peratively (mean 20.3 +/- 9.6 months), including pts with recurrent endocar
ditis and valve dehiscence, after they were successfully reoperated.
Conclusions: Along with early diagnosis and appropriate antibiotic treatmen
t, aggressive surgical attitude is of importance for the successful outcome
in this group of seriously ill patients. Our data indicate that early surg
ical treatment in cases of active endocarditis may be associated with low m
ortality and morbidity. (C) 2000 The International Society For Cardiovascul
ar Surgery. Published by Elsevier Science Ltd. All rights reserved.